latest news releases from the newsroom
ViroPharma Announces Exercise of Option to Purchase Additional Senior Convertible Notes
EXTON, Pa., April 6, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the initial investors in its 6% Senior Convertible Subordinated Notes, due October 18, 2009, have exercised in full their option to purchase $12.5 million aggregate principal amount of the Company's Senior Convertible Notes pursuant to the terms of the Securities Purchase Agreement dated October 18, 2004. With the exercise of the option, the private placement results in the issuance of $75 million aggregate principal amount of Senior Convertible Notes. The notes are convertible into shares of ViroPharma common stock at the option of the holder at any time prior to maturity at an initial conversion rate of $2.50 per share, and by ViroPharma at a price of $3.75 per share if certain conditions are met.
The Plasencia Group
The Plasencia Group Advises Intercontinental Hotels Group on the Sale of the Americas Hotel Portfolio
TAMPA, Fla., April 6, 2005 (PRIMEZONE) -- The Plasencia Group, Inc., and its affiliate, Regent Street, have completed the largest portfolio transaction in North America thus far this year on behalf of InterContinental Hotels Group, PLC with the sale of thirteen hotels valued at $425M to Hospitality Properties Trust (NYSE:HPT) and two hotels valued at $303.5M to Strategic Hotel Capital, Inc. (NYSE:SLH). The fifteen assets in the Americas portfolio include InterContinentals, Crowne Plazas, Holiday Inns and Staybridge Suites.
StockGuru.com Issues Profile Report on Bridgetech Holdings International, Inc.
DALLAS, April 6, 2005 (PRIMEZONE) -- StockGuru.com has issued a Profile Report on Bridgetech Holdings International, Inc. (Pink Sheets:BGTH). In the report authored by Shailesh Dhuri, CFA, Financial Analyst for StockGuru.com, Mr. Dhuri reports, "China's growth story is unfolding fast. For new, young businesses in the western world it would be ill-advised to ignore Chinese demand and/or the Chinese production base. However, China is difficult to maneuver. This creates opportunities to companies such as Bridgetech to offer unique solutions to new American businesses for a rewarding entry in the Chinese markets."
Vestin Group, Inc.
Vestin Chairman Initiates Tender Offer for The Company
LAS VEGAS, April 6, 2005 (PRIMEZONE) -- Vestin Group, Inc. (Pink Sheets:VSTN) announced that Michael V. Shustek, its majority shareholder, has commenced an all cash tender offer to purchase any and all of the outstanding shares of the company he does not presently own for $2.85 per share. Mr. Shustek has filed with the SEC a Tender Offer Statement on Schedule TO with respect to the offer and Vestin has filed with the SEC a Schedule 14D-9 and Schedule 13E-3. The full text of Mr. Shustek's Offer to Purchase and the related letter of transmittal and other documents have been filed with the Schedule TO. These filings contain important information; investors and shareholders are strongly advised to read them carefully before making any decision with respect to the offer.
Northrop Grumman Corp.
Northrop Grumman Introduces New Vehicle Inspection Technology
MCLEAN, Va., April 6, 2005 (PRIMEZONE) -- Northrop Grumman Corporation (NYSE:NOC) has added a new product to its suite of security and traffic management solutions. The Under Vehicle Inspection System (UVIS) provides high-resolution color images, dynamic database search functions and user-friendly software for a safer and more thorough method of inspecting vehicle undercarriages.
Amersin Life Sciences Corp.
Amersin Subsidiary Receives 30 Million RMB Contract
NEW YORK, April 6, 2005 (PRIMEZONE) -- Amersin Life Science Corporation (OTCBB:AMLS) announced today that its subsidiary, Hubei Tongji Benda Ebei Pharmaceutical Company, has been awarded a 30 million RMB sales contract (approx. 3.6 million USD) to supply a range of homeostatic, antiviral and other pharmaceuticals in injectable form to Hubei Jiuzhoutong Pharmaceutical Ltd.